Literature DB >> 16799077

Fibroblast foci are not discrete sites of lung injury or repair: the fibroblast reticulum.

Carlyne D Cool1, Steve D Groshong, Pradeep R Rai, Peter M Henson, J Scott Stewart, Kevin K Brown.   

Abstract

BACKGROUND: Usual interstitial pneumonia (UIP), the pathologic correlate of idiopathic pulmonary fibrosis, contains characteristic discrete areas of fibroblasts, myofibroblasts, and newly formed collagen, termed "fibroblast foci." These lesions are argued to represent isolated sites of recurrent acute lung injury and suggested to be the mechanism of disease progression. We hypothesized that, rather than isolated, these lesions are part of an organized neoplasm.
METHODS: Morphometric analysis of pentachrome-stained histologic sections of UIP was performed. Using point-counting technique on serial sections, fibroblast foci, arteries, and macrophage clusters were identified and we determined their individual "connectiveness" by estimating the Euler number. Two-dimensional micrographs were collated into a three-dimensional array from which a visual three-dimensional reconstruction could be constructed. Clonality analysis was performed using human androgen receptor gene methylation assay.
RESULTS: Blood vessels show significant connectivity with a Euler number of 2, whereas macrophage clusters exhibited no connectivity. The fibroblast foci showed a high level of interconnection with Euler numbers ranging from 19 to 39. The computer generated three-dimensional models provide a visual confirmation of this connectiveness. Human androgen receptor gene methylation assay analysis of the foci showed balanced methylation consistent with polyclonality.
CONCLUSIONS: The fibroblast foci of UIP are the leading edge of a complex reticulum that is highly interconnected and extends from the pleura into the underlying parenchyma. It is a reactive, rather than a malignant, process.

Entities:  

Mesh:

Year:  2006        PMID: 16799077      PMCID: PMC2648056          DOI: 10.1164/rccm.200602-205OC

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  17 in total

1.  The number of alveoli in the human lung.

Authors:  Matthias Ochs; Jens R Nyengaard; Anja Jung; Lars Knudsen; Marion Voigt; Thorsten Wahlers; Joachim Richter; Hans Jørgen G Gundersen
Journal:  Am J Respir Crit Care Med       Date:  2003-09-25       Impact factor: 21.405

2.  The roles of the myofibroblast in idiopathic pulmonary fibrosis. Ultrastructural and immunohistochemical features of sites of active extracellular matrix synthesis.

Authors:  C Kuhn; J A McDonald
Journal:  Am J Pathol       Date:  1991-05       Impact factor: 4.307

3.  An immunohistochemical study of architectural remodeling and connective tissue synthesis in pulmonary fibrosis.

Authors:  C Kuhn; J Boldt; T E King; E Crouch; T Vartio; J A McDonald
Journal:  Am Rev Respir Dis       Date:  1989-12

Review 4.  The new stereological tools: disector, fractionator, nucleator and point sampled intercepts and their use in pathological research and diagnosis.

Authors:  H J Gundersen; P Bagger; T F Bendtsen; S M Evans; L Korbo; N Marcussen; A Møller; K Nielsen; J R Nyengaard; B Pakkenberg
Journal:  APMIS       Date:  1988-10       Impact factor: 3.205

5.  Epithelial necrosis and alveolar collapse in the pathogenesis of usual interstitial pneumonia.

Authors:  J L Myers; A L Katzenstein
Journal:  Chest       Date:  1988-12       Impact factor: 9.410

6.  A histologic pattern of nonspecific interstitial pneumonia is associated with a better prognosis than usual interstitial pneumonia in patients with cryptogenic fibrosing alveolitis.

Authors:  Z D Daniil; F C Gilchrist; A G Nicholson; D M Hansell; J Harris; T V Colby; R M du Bois
Journal:  Am J Respir Crit Care Med       Date:  1999-09       Impact factor: 21.405

7.  Fibroblastic foci in usual interstitial pneumonia: idiopathic versus collagen vascular disease.

Authors:  Kevin R Flaherty; Thomas V Colby; William D Travis; Galen B Toews; Jeanette Mumford; Susan Murray; Victor J Thannickal; Ella A Kazerooni; Barry H Gross; Joseph P Lynch; Fernando J Martinez
Journal:  Am J Respir Crit Care Med       Date:  2003-02-20       Impact factor: 21.405

8.  Localisation of a pulmonary autoantigen in cryptogenic fibrosing alveolitis.

Authors:  W A Wallace; J A Schofield; D Lamb; S E Howie
Journal:  Thorax       Date:  1994-11       Impact factor: 9.139

9.  Bronchiolitis obliterans and usual interstitial pneumonia. A comparative clinicopathologic study.

Authors:  A L Katzenstein; J L Myers; W D Prophet; L S Corley; M S Shin
Journal:  Am J Surg Pathol       Date:  1986-06       Impact factor: 6.394

10.  Significance of early intra-alveolar fibrotic lesions and integrin expression in lung biopsy specimens from patients with idiopathic pulmonary fibrosis.

Authors:  Y Fukuda; F Basset; V J Ferrans; N Yamanaka
Journal:  Hum Pathol       Date:  1995-01       Impact factor: 3.466

View more
  76 in total

1.  Fibrocytes Regulate Wilms Tumor 1-Positive Cell Accumulation in Severe Fibrotic Lung Disease.

Authors:  Vishwaraj Sontake; Shiva K Shanmukhappa; Betsy A DiPasquale; Geereddy B Reddy; Mario Medvedovic; William D Hardie; Eric S White; Satish K Madala
Journal:  J Immunol       Date:  2015-09-14       Impact factor: 5.422

2.  Unique and Redundant Functions of p70 Ribosomal S6 Kinase Isoforms Regulate Mesenchymal Cell Proliferation and Migration in Pulmonary Fibrosis.

Authors:  Satish K Madala; Vishwaraj Sontake; Ramakrishna Edukulla; Cynthia R Davidson; Stephanie Schmidt; William D Hardie
Journal:  Am J Respir Cell Mol Biol       Date:  2016-12       Impact factor: 6.914

Review 3.  Conceptual approaches to lung injury and repair.

Authors:  Rachel L Zemans; Peter M Henson; Jan E Henson; William J Janssen
Journal:  Ann Am Thorac Soc       Date:  2015-03

Review 4.  Mechanisms of alveolar epithelial injury, repair, and fibrosis.

Authors:  Rachel C Chambers; Paul F Mercer
Journal:  Ann Am Thorac Soc       Date:  2015-03

Review 5.  The role of CXC chemokines in pulmonary fibrosis.

Authors:  Robert M Strieter; Brigitte N Gomperts; Michael P Keane
Journal:  J Clin Invest       Date:  2007-03       Impact factor: 14.808

6.  Protease-activated receptor-2 induces myofibroblast differentiation and tissue factor up-regulation during bleomycin-induced lung injury: potential role in pulmonary fibrosis.

Authors:  Keren Borensztajn; Paul Bresser; Chris van der Loos; Ilze Bot; Bernt van den Blink; Michael A den Bakker; Joost Daalhuisen; Angelique P Groot; Maikel P Peppelenbosch; Jan H von der Thüsen; C Arnold Spek
Journal:  Am J Pathol       Date:  2010-10-22       Impact factor: 4.307

Review 7.  Does current knowledge explain the pathogenesis of idiopathic pulmonary fibrosis? A perspective.

Authors:  Gary W Hunninghake; Marvin I Schwarz
Journal:  Proc Am Thorac Soc       Date:  2007-08-15

8.  High-resolution chest CT findings do not predict the presence of pulmonary hypertension in advanced idiopathic pulmonary fibrosis.

Authors:  David A Zisman; Arun S Karlamangla; David J Ross; Michael P Keane; John A Belperio; Rajan Saggar; Joseph P Lynch; Abbas Ardehali; Jonathan Goldin
Journal:  Chest       Date:  2007-06-15       Impact factor: 9.410

9.  NADPH oxidase-dependent formation of reactive oxygen species contributes to transforming growth factor β1-induced epithelial-mesenchymal transition in rat peritoneal mesothelial cells, and the role of astragalus intervention.

Authors:  Xiao-xian Liu; Hong-juan Zhou; Long Cai; Wen Zhang; Ji-lin Ma; Xiao-juan Tao; Jian-ning Yu
Journal:  Chin J Integr Med       Date:  2012-10-22       Impact factor: 1.978

10.  Small airways pathology in idiopathic pulmonary fibrosis: a retrospective cohort study.

Authors:  Stijn E Verleden; Naoya Tanabe; John E McDonough; Dragoş M Vasilescu; Feng Xu; Wim A Wuyts; Davide Piloni; Laurens De Sadeleer; Stijn Willems; Cindy Mai; Jeroen Hostens; Joel D Cooper; Erik K Verbeken; Johny Verschakelen; Craig J Galban; Dirk E Van Raemdonck; Thomas V Colby; Marc Decramer; Geert M Verleden; Naftali Kaminski; Tillie-Louise Hackett; Bart M Vanaudenaerde; James C Hogg
Journal:  Lancet Respir Med       Date:  2020-02-13       Impact factor: 30.700

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.